By: Richard Lindstrom, MD; Zaina Al-Mohtaseb, MD; Gerd Auffarth, MD, FEBO; Jacqueline Beltz Franzco; Marjan Farid, MD; Cristos Ifantides, MD, MBA,; Jodhbir Mehta, BSC (HONS.), MBBS, PHD, FRCOPHTH, FRCS (ED), FAMS; Prof. Sathish Srinivasan MBBS, FRCSEd, FRCOphth, FACS; and William B. Trattler, MD
This course has expired. You can still review the content but course credit is no longer available.
CONTENT SOURCE This continuing medical education (CME) activity captures content from a round table. ACTIVITY DESCRIPTION A panel of experts in ophthalmology from around the globe offer recommendations for defining, diagnosing, and treating irregular corneas. TARGET AUDIENCE This certified CME activity is designed for general ophthalmologists and specialists who treat irregular corneas.
This activity is supported by an unrestricted educational grant from Acufocus.
Upon completion of this activity, the participant should be able to:
Jointly Provided by Evolve Medical Education and The Fundingsland Group
ACCREDITATION STATEMENT This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education LLC (Evolve), and The Fundingsland Group. Evolve is accredited by the ACCME to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT Evolve Medical Education designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Course Viewing Requirements
Supported Browsers: Internet Explorer 11 for Windows Edge (recent versions; Chromium-based) for Windows Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux Safari (recent versions) for Mac OSX, or iOS
Hardware Requirements: 4GB+ RAM
Recommended internet speed 5Mbps+
Richard Lindstrom, MD (Moderator)
Program Director
Founder and Attending Surgeon
Minnesota Eye Consultants
Minneapolis, Minnesota
Zaina Al-Mohtaseb, MD
Associate Professor of Ophthalmology
Associate Residency Program Director, Cornea, Cataract, and Refractive Surgery
Baylor College of Medicine
Houston, Texas
Gerd Auffarth, MD, FEBO
Chairman, Department of Ophthalmology, Heidelberg University Eye Hospital
Director (Head), International Vision Correction Research Centre
Director (Head), David J. Apple Center for Vision Research
Jacqueline Beltz Franzco
Corneal, Cataract, And Refractive Surgeon
Eye Surgery Associates and Royal Victorian Eye and Ear Hospital
Melbourne, Australia
Marjan Farid, MD
Director of Cornea, Cataract, and Refractive Surgery
Vice Chair of Ophthalmic Faculty
Clinical Professor of Ophthalmology
Gavin Herbert Eye Institute
University of California, Irvine
Cristos Ifantides, MD, MBA,
Assistant Professor of Ophthalmology
University of Colorado Anschutz Medical Campus
Aurora, Colorado
Jodhbir Mehta, BSC (HONS.), MBBS, PHD, FRCOPHTH, FRCS (ED), FAMS
Distinguished Professor in Clinical Innovation in Ophthalmology
Department of Ophthalmology
Yong Loo Lin School of Medicine
National University of Singapore
Prof. Sathish Srinivasan MBBS, FRCSEd, FRCOphth, FACS
Founder and Medical Director, Ayrshire Eye Clinic
Scotland
William B. Trattler, MD
Cornea, Cataract and Refractive Surgeon
Center for Excellence in Eye Care
Miami, Florida
Clinical Associate Professor
Herbert Wertheim College of Medicine at Florida International University
Miami, Florida
Richard Lindstrom, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant and Stock/Shareholder: Acufocus.
Zaina Al-Mohtaseb, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon Vision, Bausch + Lomb, Carl Zeiss Meditec, Corneagen, and Ocular Therapeutix.
Gerd Auffarth, MD, FEBO, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: EyeYon, Oculus, and Presbia. Grant/Research Support: Alcon, Bausch + Lomb, Carl Zeiss Meditec, Contacmac, Hoya, Johnson & Johnson Vision, Oculus, and SIFI. Speaker’s Bureau: Acufocus, Alcon, Bausch + Lomb, Carl Zeiss Meditec, Hoya, Johnson & Johnson Vision, Oculus, and SIFI.
Jacqueline Beltz Franzco, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: AcuFocus, Alcon, Glaukos, and Novartis. Grant/Research Support: Johnson & Johnson Vision.
Marjan Farid, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Bio-Tissue, Carl Zeiss Meditec, Corneagen, Dompe, Eyepoint, Eyevance, Johnson & Johnson Vision, Kala, and Novartis.
Cristos Ifantides, MD, MBA,, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant and Speaker’s Bureau: Centricity Vision. Grant/Research Support: New World Medical. Stock/Shareholder: AbbVie, Amwell, GoodRx, and Pfizer. Other Financial Material Support: AbbVie, Hu-Med Tech, Spect Inc., and Vision 2020 USA.
Jodhbir Mehta, BSC (HONS.), MBBS, PHD, FRCOPHTH, FRCS (ED), FAMS, has no financial relationships with commercial interests.
Prof. Sathish Srinivasan MBBS, FRCSEd, FRCOphth, FACS, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Acufocus, Alcon, Carl Zeiss Meditec, Dutch Ophthalmic Research Center, Medicontur, Scope Ophthalmalics, and Thea.
William B. Trattler, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Bausch + Lomb, Carl Zeiss Meditec, Johnson & Johnson Vision, and Oculus.Grant/Research: Carl Zeiss Meditec. Speaker’s Bureau: Alcon, Carl Zeiss Meditec, Johnson & Johnson Vision, and Oculus. Stock/Shareholder: Avedro and CSLO.
EDITORIAL SUPPORT DISCLOSURES The staff and planners from Evolve and The Fundingsland Group have no financial relationships with commercial interests. Diane Diane Angelucci, writer, and Nisha Mukherjee, MD, peer reviewer, have no financial relationships with commercial interests.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, The Fundingsland Group, Cataract & Refractive Surgery Today, Cataract & Refractive Surgery Today Europe, or Acufocus.